Youngil Koh

609 total citations
19 papers, 274 citations indexed

About

Youngil Koh is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Youngil Koh has authored 19 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 6 papers in Genetics and 6 papers in Oncology. Recurrent topics in Youngil Koh's work include Lymphoma Diagnosis and Treatment (17 papers), T-cell and Retrovirus Studies (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Youngil Koh is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), T-cell and Retrovirus Studies (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Youngil Koh collaborates with scholars based in South Korea, China and United States. Youngil Koh's co-authors include Sung‐Soo Yoon, Won Seog Kim, Seok Jin Kim, Sang Eun Yoon, Junhun Cho, Young Hyeh Ko, Yurike Laurensia, Ji Young Lee, Duck Cho and Choon Kiat Ong and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Youngil Koh

17 papers receiving 268 citations

Peers

Youngil Koh
Bertrand Joly France
Julie Lisano United States
Emanuela Anna Pesce Italy
Florence Broussais‐Guillaumot France
Claudia Castañeda Mexico
S. Venturi Italy
M. Dreyling Germany
Cristina Becchimanzi Italy
Zdravko Mitrović Croatia
Bertrand Joly France
Youngil Koh
Citations per year, relative to Youngil Koh Youngil Koh (= 1×) peers Bertrand Joly

Countries citing papers authored by Youngil Koh

Since Specialization
Citations

This map shows the geographic impact of Youngil Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youngil Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youngil Koh more than expected).

Fields of papers citing papers by Youngil Koh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youngil Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youngil Koh. The network helps show where Youngil Koh may publish in the future.

Co-authorship network of co-authors of Youngil Koh

This figure shows the co-authorship network connecting the top 25 collaborators of Youngil Koh. A scholar is included among the top collaborators of Youngil Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youngil Koh. Youngil Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Byun, Ja Min, et al.. (2025). Impact of induction regimens on stem cell mobilization yields in newly diagnosed multiple myeloma. Annals of Hematology. 104(4). 2297–2304.
2.
Koh, Youngil, et al.. (2024). Abstract 2265: Distinct alternative splicing patterns in genetic subtypes of diffuse large B-cell lymphoma. Cancer Research. 84(6_Supplement). 2265–2265. 1 indexed citations
3.
Lee, Jung‐Kyu, et al.. (2024). Clonal haematopoiesis of indeterminate potential: a risk factor for future exacerbation in patients with COPD. ERJ Open Research. 11(3). 292–2024. 1 indexed citations
4.
Byun, Ja Min, Junshik Hong, Youngil Koh, et al.. (2024). Treatment outcomes and prognostic factors of patients with lymphoblastic lymphoma in East Asia. Medicine. 103(7). e37100–e37100.
5.
Song, Yuqin, Dok Hyun Yoon, Haiyan Yang, et al.. (2023). Phase I dose escalation and expansion study of golidocitinib, a highly selective JAK1 inhibitor, in relapsed or refractory peripheral T-cell lymphomas. Annals of Oncology. 34(11). 1055–1063. 8 indexed citations
6.
Koh, Youngil. (2021). Genomics of diffuse large B cell lymphoma. Blood Research. 56(S1). S75–S79. 5 indexed citations
7.
Song, Yuqin, Youngil Koh, Ji Cao, et al.. (2021). EARLY SAFETY AND EFFICACY DATA FROM A PHASE I/II TRIAL OF DZD4205, A SELECTIVE JAK1 INHIBITOR, IN RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA. Hematological Oncology. 39(S2). 3 indexed citations
8.
Jeong, Hyehyun, Motoko Yamaguchi, Insuk Sohn, et al.. (2020). Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphoma. Blood. 136(22). 2548–2556. 17 indexed citations
9.
Koh, Youngil, et al.. (2020). Synergistic Effect of Alectinib and Everolimus on ALK-positive Anaplastic Large Cell Lymphoma Growth Inhibition. Anticancer Research. 40(3). 1395–1403. 6 indexed citations
10.
Yoon, Sang Eun, Seung Ju Kim, Dok Hyun Yoon, et al.. (2020). 257O Intercontinental cooperative non-Hodgkin T-cell lymphoma prospective registry study in Asia: ICT study. Annals of Oncology. 31. S1343–S1344. 1 indexed citations
11.
Kim, Seok Jin, Jing Quan Lim, Yurike Laurensia, et al.. (2020). Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study. Blood. 136(24). 2754–2763. 91 indexed citations
12.
Kim, Won-Seog, Hyeon‐Seok Eom, Youngil Koh, et al.. (2020). A Phase I/II Study (JACKPOT8) of DZD4205, a Selective JAK1 Inhibitor, in Refractory or Relapsed Peripheral T- Cell Lymphoma. Blood. 136(Supplement 1). 19–20. 3 indexed citations
13.
Yhim, Ho‐Young, Seung Ju Kim, Ho‐Jin Shin, et al.. (2020). Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial. Annals of Oncology. 32(4). 552–559. 16 indexed citations
14.
Cheon, Gi Jeong, Youngil Koh, Min Young Yoo, et al.. (2019). Prognostic value of metabolic tumour volume on baseline 18F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI. European Journal of Nuclear Medicine and Molecular Imaging. 46(7). 1417–1427. 58 indexed citations
15.
Hong, Jung Yong, Dok Hyun Yoon, Sang Eun Yoon, et al.. (2019). Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis. Scientific Reports. 9(1). 20302–20302. 11 indexed citations
16.
Park, Jihyun, Sungyoung Lee, Hongseok Yun, et al.. (2019). Abstract 1248: Not BCL2 but BFL1 is overexpressed and have strong correlation with NF-kB pathway in diffuse large B-cell lymphoma. Cancer Research. 79(13_Supplement). 1248–1248. 1 indexed citations
17.
18.
Jeong, Seong Hyun, Haa‐Na Song, Joon Seong Park, et al.. (2018). Allogeneic Stem Cell Transplantation for Patients with Natural Killer/T Cell Lymphoid Malignancy: A Multicenter Analysis Comparing Upfront and Salvage Transplantation. Biology of Blood and Marrow Transplantation. 24(12). 2471–2478. 24 indexed citations
19.
Kim, Young Ae, Ja Min Byun, Keeho Park, et al.. (2017). Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma. Blood Advances. 1(24). 2138–2146. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bertrand Joly Breakdown of academic impact, for papers by Julie Lisano Breakdown of academic impact, for papers by Emanuela Anna Pesce Breakdown of academic impact, for papers by Florence Broussais‐Guillaumot Breakdown of academic impact, for papers by Claudia Castañeda Breakdown of academic impact, for papers by S. Venturi Breakdown of academic impact, for papers by M. Dreyling Breakdown of academic impact, for papers by Cristina Becchimanzi Breakdown of academic impact, for papers by Zdravko Mitrović
Rankless by CCL
2026